Non-Toxigenic Strain E4 (NTCD-E4) Prevents Establishment of Primary Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model.

infection (CDI) remains a significant healthcare burden. Non-toxigenic (NTCD) strains have shown a benefit in preventing porcine enteritis and in human recurrent CDI. In this study, we evaluated the efficacy of metronidazole-resistant NTCD-E4 in preventing CDI facilitated by a range of antimicrobials in an in vitro human gut model.